The University of Chicago Header Logo

Connection

Elbert Huang to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Elbert Huang has written about Diabetes Mellitus, Type 2.
Elbert Huang
Connection Strength
10.548
Diabetes Mellitus, Type 2
  1. Individualizing Care for Older Adults With Diabetes Amid the Revolution in Pharmacotherapy. JAMA Intern Med. 2024 04 01; 184(4):435-436.
    View in: PubMed
    Score: 0.445
  2. Moderation of associations between weight discrimination and diabetes status by psychosocial factors. J Behav Med. 2024 04; 47(2):244-254.
    View in: PubMed
    Score: 0.433
  3. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 04; 176(4):eL230007.
    View in: PubMed
    Score: 0.415
  4. Data-driven classification of health status of older adults with diabetes: The diabetes and aging study. J Am Geriatr Soc. 2023 07; 71(7):2120-2130.
    View in: PubMed
    Score: 0.413
  5. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S113-S124.
    View in: PubMed
    Score: 0.381
  6. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S39-S45.
    View in: PubMed
    Score: 0.381
  7. The Cost and Safety of Insulin in Older Adults. JAMA Intern Med. 2021 05 01; 181(5):608-609.
    View in: PubMed
    Score: 0.364
  8. National physician survey on glycemic goals and medical decision making for patients with type 2 diabetes. Medicine (Baltimore). 2019 Dec; 98(51):e18491.
    View in: PubMed
    Score: 0.330
  9. Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Med Decis Making. 2019 02; 39(2):137-151.
    View in: PubMed
    Score: 0.310
  10. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
    View in: PubMed
    Score: 0.288
  11. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study. J Diabetes Complications. 2017 01; 31(1):94-100.
    View in: PubMed
    Score: 0.261
  12. Impact and Feasibility of Personalized Decision Support for Older Patients with Diabetes: A Pilot Randomized Trial. Med Decis Making. 2017 07; 37(5):611-617.
    View in: PubMed
    Score: 0.259
  13. Management of diabetes mellitus in older people with comorbidities. BMJ. 2016 06 15; 353:i2200.
    View in: PubMed
    Score: 0.259
  14. Potential Overtreatment of Older, Complex Adults With Diabetes. JAMA. 2015 Sep 22-29; 314(12):1280-1.
    View in: PubMed
    Score: 0.245
  15. Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care. 2014 Dec; 37(12):3188-95.
    View in: PubMed
    Score: 0.230
  16. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
    View in: PubMed
    Score: 0.214
  17. Personalized decision support in type 2 diabetes mellitus: current evidence and future directions. Curr Diab Rep. 2013 Apr; 13(2):205-12.
    View in: PubMed
    Score: 0.208
  18. Impact of delaying blood pressure control in patients with Type 2 diabetes: results of a decision analysis. J Gen Intern Med. 2012 Jun; 27(6):640-6.
    View in: PubMed
    Score: 0.191
  19. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011 Jun; 34(6):1329-36.
    View in: PubMed
    Score: 0.181
  20. The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study. J Gen Intern Med. 2010 Feb; 25(2):141-6.
    View in: PubMed
    Score: 0.165
  21. Changes in racial/ethnic disparities in the prevalence of Type 2 diabetes by obesity level among US adults. Ethn Health. 2009 Oct; 14(5):439-57.
    View in: PubMed
    Score: 0.163
  22. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009 Feb; 32(2):311-6.
    View in: PubMed
    Score: 0.153
  23. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008 Jul 01; 149(1):11-9.
    View in: PubMed
    Score: 0.149
  24. Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients. J Am Geriatr Soc. 2008 Jul; 56(7):1183-90.
    View in: PubMed
    Score: 0.148
  25. Implications of new geriatric diabetes care guidelines for the assessment of quality of care in older patients. Med Care. 2006 Apr; 44(4):373-7.
    View in: PubMed
    Score: 0.128
  26. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006 Feb; 29(2):259-64.
    View in: PubMed
    Score: 0.126
  27. Development and Internal Validation of the Multiethnic Type 2 Diabetes Outcomes Model for the U.S. (DOMUS). Diabetes Care. 2025 Nov 01; 48(11):1942-1950.
    View in: PubMed
    Score: 0.124
  28. Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies. Lancet Diabetes Endocrinol. 2025 05; 13(5):427-437.
    View in: PubMed
    Score: 0.118
  29. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc. 2005 Feb; 53(2):306-11.
    View in: PubMed
    Score: 0.118
  30. Deprescribing in Older Adults With Type 2 Diabetes: Associations With Patients' Perspectives: The Diabetes and Aging Study. J Am Geriatr Soc. 2025 04; 73(4):1155-1167.
    View in: PubMed
    Score: 0.117
  31. The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes. Appl Health Econ Health Policy. 2024 11; 22(6):861-869.
    View in: PubMed
    Score: 0.115
  32. Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population. Diabetes Obes Metab. 2024 11; 26(11):5261-5271.
    View in: PubMed
    Score: 0.115
  33. Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysis. Diabetes Care. 2024 09 01; 47(9):1704-1712.
    View in: PubMed
    Score: 0.115
  34. Practical challenges of individualizing diabetes care in older patients. Diabetes Educ. 2004 Jul-Aug; 30(4):558, 560, 562 passim.
    View in: PubMed
    Score: 0.113
  35. Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study. J Gen Intern Med. 2024 10; 39(13):2400-2406.
    View in: PubMed
    Score: 0.112
  36. Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study. J Am Geriatr Soc. 2024 07; 72(7):1985-1994.
    View in: PubMed
    Score: 0.111
  37. Health care resource utilization associated with a diabetes center and a general medicine clinic. J Gen Intern Med. 2004 Jan; 19(1):28-35.
    View in: PubMed
    Score: 0.109
  38. Costs and Health Care Utilization Analysis of Medical Group Visits for Adults With Type 2 Diabetes in Community Health Centers. Med Care. 2023 12 01; 61(12):866-871.
    View in: PubMed
    Score: 0.108
  39. Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study. J Am Geriatr Soc. 2023 12; 71(12):3692-3700.
    View in: PubMed
    Score: 0.107
  40. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.100
  41. Quality of Care for US Adults With Medicaid Insurance and Type 2 Diabetes in Federally Qualified Health Centers Compared With Other Primary Care Settings. Med Care. 2022 11 01; 60(11):813-820.
    View in: PubMed
    Score: 0.100
  42. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med. 2001 Dec 01; 111(8):633-42.
    View in: PubMed
    Score: 0.095
  43. Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
    View in: PubMed
    Score: 0.095
  44. The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
    View in: PubMed
    Score: 0.093
  45. Analyzing Medical Guideline Dissemination Behaviors Using Culturally Infused Agent Based Modeling Framework. IEEE J Biomed Health Inform. 2021 06; 25(6):2137-2149.
    View in: PubMed
    Score: 0.091
  46. Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
    View in: PubMed
    Score: 0.082
  47. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019 12; 42(12):2247-2255.
    View in: PubMed
    Score: 0.081
  48. The Impact of the Affordable Care Act Medicaid Expansion on Type 2 Diabetes Diagnosis and Treatment: A National Survey of Physicians. J Community Health. 2019 06; 44(3):463-472.
    View in: PubMed
    Score: 0.080
  49. Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:416-426. Diabetes Care. 2019 03; 42(3):e46-e47.
    View in: PubMed
    Score: 0.078
  50. Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers. J Hypertens. 2018 11; 36(11):2177-2184.
    View in: PubMed
    Score: 0.076
  51. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care. 2019 03; 42(3):416-426.
    View in: PubMed
    Score: 0.075
  52. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
    View in: PubMed
    Score: 0.075
  53. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia. 2018 09; 61(9):1956-1965.
    View in: PubMed
    Score: 0.075
  54. The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes. Diabetes Care. 2018 01; 41(1):104-111.
    View in: PubMed
    Score: 0.071
  55. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017 10 01; 177(10):1461-1470.
    View in: PubMed
    Score: 0.071
  56. Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2017 12; 40(12):1661-1667.
    View in: PubMed
    Score: 0.071
  57. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complications. 2017 Mar; 31(3):556-561.
    View in: PubMed
    Score: 0.067
  58. Racial and Ethnic Disparities in Diabetes Screening Between Asian Americans and Other Adults: BRFSS 2012-2014. J Gen Intern Med. 2017 Apr; 32(4):423-429.
    View in: PubMed
    Score: 0.067
  59. Physician perspectives on de-intensifying diabetes medications. Medicine (Baltimore). 2016 Nov; 95(46):e5388.
    View in: PubMed
    Score: 0.067
  60. Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus. J Am Geriatr Soc. 2017 01; 65(1):77-82.
    View in: PubMed
    Score: 0.066
  61. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.059
  62. Severe diabetic retinal disease and dementia risk in type 2 diabetes. J Alzheimers Dis. 2014; 42 Suppl 3:S109-17.
    View in: PubMed
    Score: 0.055
  63. Racial/ethnic differences in dementia risk among older type 2 diabetic patients: the diabetes and aging study. Diabetes Care. 2014 Apr; 37(4):1009-15.
    View in: PubMed
    Score: 0.054
  64. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013 Nov; 1(3):183-90.
    View in: PubMed
    Score: 0.053
  65. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013 Nov; 36(11):3535-42.
    View in: PubMed
    Score: 0.053
  66. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. Value Health. 2013 Jun; 16(4):670-85.
    View in: PubMed
    Score: 0.052
  67. Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study. J Gen Intern Med. 2012 Dec; 27(12):1674-81.
    View in: PubMed
    Score: 0.050
  68. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry. 2012 Apr; 69(4):410-7.
    View in: PubMed
    Score: 0.047
  69. The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients. Med Care Res Rev. 2010 Oct; 67(5 Suppl):163S-197S.
    View in: PubMed
    Score: 0.043
  70. Communicating with older diabetes patients: self-management and social comparison. Patient Educ Couns. 2008 Sep; 72(3):411-7.
    View in: PubMed
    Score: 0.037
  71. The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients. Curr Med Res Opin. 2006 Nov; 22(11):2301-11.
    View in: PubMed
    Score: 0.033
  72. Diabetes in older adults. Diabetes Care. 2012 Dec; 35(12):2650-64.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.